4//SEC Filing
German Christopher Paul 4
Accession 0001104659-25-058954
CIK 0001649904other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:50 PM ET
Size
9.1 KB
Accession
0001104659-25-058954
Insider Transaction Report
Form 4
German Christopher Paul
Corporate Controller & CAO
Transactions
- Exercise/Conversion
Common Stock
2025-06-10$17.97/sh+1,069$19,210→ 3,958 total - Exercise/Conversion
Stock Options (Right to Buy)
2025-06-10−1,069→ 8,231 totalExercise: $17.97Exp: 2033-04-03→ Common Stock (1,069 underlying) - Sale
Common Stock
2025-06-10$67.19/sh−2,069$139,016→ 1,889 total
Footnotes (2)
- [F1]The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2025
- [F2]The stock options were granted on April 4, 2023. The options vest and become exercisable as to 25% of the total shares on March 20, 2024 and, thereafter, as to the remaining 75% of the total shares in twelve equal quarterly installments of 6.25% beginning June 20, 2024 and ending March 20, 2027, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
RHYTHM PHARMACEUTICALS, INC.
CIK 0001649904
Entity typeother
Related Parties
1- filerCIK 0001260835
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:50 PM ET
- Size
- 9.1 KB